Singapore markets open in 6 hours 40 minutes

Karyopharm Therapeutics Inc. (KPTI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.1100-0.0100 (-0.89%)
As of 02:19PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts7777
Avg. Estimate-0.31-0.3-1.22-0.87
Low estimate-0.34-0.32-1.32-1.25
High estimate-0.29-0.28-1.15-0.57
Year ago EPS-0.29-0.3-1.25-1.22
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts7777
Avg. Estimate36.18M37.6M144.87M165.17M
Low estimate33.6M36.22M140.1M130.09M
High estimate38.11M40.21M148.71M209.72M
Year ago sales37.58M36.01M146.03M144.87M
Sales growth (year/est)-3.70%4.40%-0.80%14.00%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.34-0.28-0.31-0.33
Actual EPS-0.29-0.3-0.36-0.32
Difference0.05-0.02-0.050.01
Surprise %14.70%-7.10%-16.10%3.00%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.31-0.3-1.22-0.87
7 days ago-0.31-0.3-1.22-0.87
30 days ago-0.31-0.3-1.23-1.01
60 days ago-0.31-0.3-1.23-1.01
90 days ago-0.3-0.3-1.1-1.01
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days2345
Down last 7 daysN/AN/AN/AN/A
Down last 30 days111N/A
Growth estimatesKPTIIndustrySector(s)S&P 500
Current qtr.-6.90%N/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current year2.40%N/AN/AN/A
Next year28.70%N/AN/AN/A
Next 5 years (per annum)-30.30%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A